Cadence Partners with Antiviral Discovery Consortium to Spearhead Rapid Development of Treatments for Viral Pandemics

A US company has secured $68m (27m) funding to help develop a rapid antiviral drug discovery pipeline using artificial intelligence (AI) and machine learning, according to the US National Institute of Allergy and Infectious Diseases (NIAID) in the U19 Center for Pathologists of Pandemic Concern (U19) at Santa Fe. (). One of the world s leading scientists has launched an effort to develop an anti-viral vaccine against Covid-19 which is being developed by the University of California. Scientists have been given access to software that helps researchers develop antiviral drugs to prevent future pandemics and prevent the spread of coronavirus. The US government says it is thrilled to be able to launch their efforts to become the first public service to provide innovative tools to boost the development of an effective antiviral therapy infrastructure. But what does it mean for the coronavirus vaccinations, and how could it be used to tackle the Covid infections in developing diseases such as Covid-19, including coronavirus, as part of US research initiatives? Why is it so important? The BBC has learned about the technology behind the launch of one of its software developers, Cadence M al Sciences (CDNA) software to support the project. ASAP Discovery Consortium has been awarded $67m NSA grant. Here is what they say is the biggest achievements of this years US schemes for those involved in researching the virus.

Source: streetinsider.com
Published on 2023-12-07